Today on Outsourcing-Pharma.com   Morphosys to exit fee-for-service upon Novartis deal eClinical potential explored CMC buys Lilly/ICOS facility Addex and Merck target new cure for Parkinson's India's Glenmark pioneering through prioritising preclinical

Related Industry News   Almirall takes on big pharma in COPD Merck heads to Ireland for new 200m site A spoonful of foam helps the medicine go down AstraZeneca finds buyer for German plant

Breaking News on Outsourcing Pharma
Daily  Wednesday 05 December 2007		Forward to a colleague

	Sponsored Link Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here Access Full Stories Morphosys to exit fee-for-service upon Novartis deal Morphosys has landed in the money after scoring a lucrative 10 year antibody development deal with Novartis and as a result, will now place all its eggs in one basket and cut ties with its fee-for-service customers... Read eClinical potential explored As eClinical gathers momentum, Outsourcing-Pharma.com spoke to two contract research organisations (CROs), Icon and Parexel, to get their views on the present and future of these emerging technologies... Read CMC buys Lilly/ICOS facility Denmark-based CMC Biopharmaceuticals has snapped up Eli Lilly's recently acquired biologics facility for an undisclosed amount... Read Addex and Merck target new cure for Parkinson's Merck & Co. has entered into an exclusive collaboration and licensing deal with Addex Pharma to develop a new class of orally available Parkinson's therapies... Read India's Glenmark pioneering through prioritising preclinical Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority... Read
	All News Headlines for: December | November | October
	Related Industry News Almirall takes on big pharma in COPD Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house... Read Merck heads to Ireland for new 200m site Merck has settled on a site in south east Ireland for a new vaccines and biologics facility, investing €200m ($280m) in its third facility on the island... Read A spoonful of foam helps the medicine go down Is it a liquid? Is it a solid?.........No, it's 'foam-on-a-spoon'... Read AstraZeneca finds buyer for German plant Reports emerged in the German press yesterday claiming that AstraZeneca has found a buyer for its Plankstadt manufacturing facility... Read Weekly Comment No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma. Read Previous Headlines eClinical news in Brief Outsourcing-Pharma tracks the latest eClinical news, featuring etrials and Phase Forward... Read Covance divests cardiac unit Covance has announced the $35m sale of its electrocardiogram (ECG) unit in order to focus on its core businesses... Read Boehringer boosts biopharma base Boehringer Ingelheim has completed a hefty makeover of its biopharmaceutical production plant in Biberach, Germany... Read Pharmaceutical outsourcing: people on the move Patheon, Parexel, and others have all had people on the move in the world of pharmaceutical outsourcing... Read Pfizer plans more off-shoring and outsourcing Pfizer is looking to Asia for both R&D and manufacturing outsourcing and to help it cut costs in a bid to mitigate the effects of patent expiries and competition from generic drugs... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com